603799:SSEZhejiang Huayou Cobalt Co., Ltd. Class A Analysis
Data as of 2026-03-16 - not real-time
CN¥63.42
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Zhejiang Huayou Cobalt is trading well below its 30‑day simple moving averages and the DCF‑derived fair value of roughly CNY 150, indicating a substantial valuation gap. The stock sits just above the identified support around CNY 62, with an RSI in the low‑30s suggesting oversold conditions, while the MACD remains in a bearish configuration. Revenue is expanding at a rapid 40% pace and forward earnings estimates point to a much tighter PE near 11×, but the balance sheet is strained by a debt‑to‑equity ratio above 100% and negative free cash flow, raising concerns about dividend sustainability.
Given the extreme “greed” sentiment in the market and a low beta implying limited price volatility, the upside potential from the valuation disconnect is tempered by liquidity and leverage risks. Investors should weigh the attractive upside against the cash‑flow and debt challenges when forming a view.
Given the extreme “greed” sentiment in the market and a low beta implying limited price volatility, the upside potential from the valuation disconnect is tempered by liquidity and leverage risks. Investors should weigh the attractive upside against the cash‑flow and debt challenges when forming a view.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 6/10
Key Factors
- Price near technical support with oversold RSI
- Large valuation gap to DCF fair value
- Stable volume providing liquidity for entry
Medium Term
1–3 yearsNeutral
Model confidence: 7/10
Key Factors
- Strong revenue growth and improving forward PE
- High leverage and negative free cash flow
- Battery‑material demand tailwinds supporting earnings
Long Term
> 3 yearsPositive
Model confidence: 5/10
Key Factors
- Long‑term secular growth in EV and battery markets
- Significant upside implied by DCF valuation
- Need for balance‑sheet deleveraging to sustain dividends
Key Metrics & Analysis
Financial Health
Revenue Growth40.90%
Profit Margin7.19%
P/E Ratio20.6
ROE12.16%
ROA3.55%
Debt/Equity101.35
P/B Ratio2.3
Op. Cash FlowCN¥12.8B
Free Cash FlowCN¥-11364334592
Technical Analysis
TrendNeutral
RSI33.8
SupportCN¥61.85
ResistanceCN¥80.10
MA 20CN¥71.54
MA 50CN¥72.76
MA 200CN¥55.74
MACDBearish
VolumeStable
Fear & Greed Index79.25
Valuation
Fair ValueCN¥152.62
GradeUndervalued
TypeBlend
Dividend Yield0.75%
Risk Assessment
Beta0.26
Volatility54.00%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.